Search

Search results

107 results found

Tie2 activation protects against prothrombotic endothelial dysfunction in COVID-19.

Publication: Journal Article

Schmaier, Alec A, Gabriel M Pajares Hurtado, Zachary J Manickas-Hill, Kelsey D Sack, Siyu M Chen, Victoria Bhambhani, Juweria Quadir, et al. 2021. “Tie2 Activation Protects Against Prothrombotic Endothelial Dysfunction in COVID-19.”. JCI Insight 6 (20).

Regulated release of nitric oxide by nonhematopoietic stroma controls expansion of the activated T cell pool in lymph nodes.

Publication: Journal Article

Lukacs-Kornek, Veronika, Deepali Malhotra, Anne L Fletcher, Sophie E Acton, Kutlu G Elpek, Prakriti Tayalia, Ai-ris Collier, and Shannon J Turley. 2011. “Regulated Release of Nitric Oxide by Nonhematopoietic Stroma Controls Expansion of the Activated T Cell Pool in Lymph Nodes.”. Nature Immunology 12 (11): 1096-104.

Deaf1 isoforms control the expression of genes encoding peripheral tissue antigens in the pancreatic lymph nodes during type 1 diabetes.

Publication: Journal Article

Yip, Linda, Leon Su, Deqiao Sheng, Pearl Chang, Mark Atkinson, Margaret Czesak, Paul R Albert, et al. 2009. “Deaf1 Isoforms Control the Expression of Genes Encoding Peripheral Tissue Antigens in the Pancreatic Lymph Nodes During Type 1 Diabetes.”. Nature Immunology 10 (9): 1026-33.

Interleukin-15/interleukin-15R alpha complexes promote destruction of established tumors by reviving tumor-resident CD8+ T cells.

Publication: Journal Article

Epardaud, Mathieu, Kutlu G Elpek, Mark P Rubinstein, Ai-ris Yonekura, Angelique Bellemare-Pelletier, Roderick Bronson, Jessica A Hamerman, Ananda W Goldrath, and Shannon J Turley. 2008. “Interleukin-15/Interleukin-15R Alpha Complexes Promote Destruction of Established Tumors by Reviving Tumor-Resident CD8+ T Cells.”. Cancer Research 68 (8): 2972-83.

Reports describe good maternal RSV vaccine, drug uptake in their first season

News: February 19, 2025

A study today in JAMA Network Open from the University of California, San Francisco (UCSF), shows a high uptake of respiratory syncytial virus (RSV) vaccine and the RSV-preventing monoclonal antibody nirsevimab among pregnant women seen during the 2023-24 season, the first RSV season the vaccine and...

Bridget Wixted

Person: Laboratory Research Assistant

Melissa Dzinoreva, BA

Person: Medical Student, Stanford

Tina Yi Jin Hsieh, MD, MPH, MS

Person: Postdoctoral Research Fellow

Emily Stonestreet, BS

Person: Clinical Research Coordinator

Tyler Lueck, MD

Person: Maternal Fetal Medicine Fellow